About
dsRNA viral mimic
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyVirginia, DC, DE & Maryland
Clinical Trials (26)
View allTotal Trials
26
As Lead Sponsor
4
As Collaborator
22
Total Enrollment
693
By Phase
PHASE1/PHASE2: 9PHASE2: 5PHASE1: 11EARLY_PHASE1: 1
By Status
COMPLETED: 16RECRUITING: 4TERMINATED: 3ACTIVE_NOT_RECRUITING: 2WITHDRAWN: 1
Clinical Trials Pipeline26 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06782932Collaborator
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
PHASE1/PHASE2Recruiting
38 participants
Started: May 27, 2025 · Completed: Dec 31, 2028
NCT06064279Collaborator
Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC
PHASE1/PHASE2Withdrawn
Started: Jun 4, 2024 · Completed: Jun 4, 2024
NCT05950139Collaborator
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
PHASE1/PHASE2Recruiting
12 participants
Started: May 13, 2024 · Completed: Jul 31, 2029
NCT06343077Collaborator
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
PHASE2Recruiting
114 participants
Started: Jan 16, 2024 · Completed: Dec 31, 2026
NCT03219450Collaborator
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
PHASE1Recruiting
15 participants
Started: Aug 18, 2021 · Completed: Mar 31, 2028
Locations (1)
Headquarters
Washington, DC, United States
Map
Loading map...